ID   SNT-16
AC   CVCL_A676
SY   SNT16
DR   Wikidata; Q54955076
RX   PubMed=12780797;
RX   PubMed=22102884;
RX   PubMed=36094314;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
RX   PubMed=12780797; DOI=10.1046/j.1365-2141.2003.04359.x;
RA   Zhang Y., Nagata H., Ikeuchi T., Mukai H., Oyoshi M.K., Demachi A.,
RA   Morio T., Wakiguchi H., Kimura N., Shimizu N., Yamamoto K.;
RT   "Common cytological and cytogenetic features of Epstein-Barr virus
RT   (EBV)-positive natural killer (NK) cells and cell lines derived from
RT   patients with nasal T/NK-cell lymphomas, chronic active EBV infection
RT   and hydroa vacciniforme-like eruptions.";
RL   Br. J. Haematol. 121:805-814(2003).
//
RX   PubMed=22102884; DOI=10.1371/journal.pone.0027271; PMCID=PMC3213120;
RA   Ramakrishnan R., Donahue H., Garcia D., Tan J., Shimizu N., Rice A.P.,
RA   Ling P.D.;
RT   "Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects
RT   growth rate of nasal NK T cell lymphomas.";
RL   PLoS ONE 6:e27271.1-e27271.12(2011).
//
RX   PubMed=36094314; DOI=10.1128/JVI.00739-22; PMCID=PMC9517713;
RA   Ding W.-Y., Wang C., Narita Y., Wang H.-B., Leong M.M.L., Huang A.,
RA   Liao Y.-F., Liu X.-F., Okuno Y., Kimura H., Gewurz B.E., Teng M.-X.,
RA   Jin S.-L., Sato Y., Zhao B.;
RT   "The Epstein-Barr virus enhancer interaction landscapes in
RT   virus-associated cancer cell lines.";
RL   J. Virol. 96:e00739.22.1-e00739.22.11(2022).
//